Kinetics of peritoneal protein loss during CAPD: I. Different characteristics for low and high molecular weight proteins  by Kagan, Alexander et al.
Kidney International, Vol. 37 (1990), PP. 971—979
Kinetics of peritoneal protein loss during CAPD: I. Different
characteristics for low and high molecular weight proteins
ALEXANDER KAGAN, YAACOV BAR-KHAYIM, ZEHAVA SCHAFER, and MENAHEM FAINARU
Lipid Research Laboratory, Department of Medicine 'A', and Division of Nephrology, Kaplan Hospital, Rehovot, Israel
Kinetics of peritoneal protein loss during CAPD: I. Different charac-
teristics for low and high molecular weight proteins. We studied the
peritoneal protein loss in 13 patients during CAPD using 2 liters of 1.5%
dextrose dialysis solutions. We compared the kinetic characteristics of
the peritoneal mass transfer and clearance of proteins over a wide range
of molecular size, to those of small molecular weight solutes. The
pentoneal clearance of all studied proteins and solutes correlated
strongly and negatively with their molecular mass. No changes were
observed in these clearances during 58 months of dialysis. Unlike the
peritoneal mass transfer and clearance of small molecular weight
solutes (< 200) which revealed a remarkable progressive drop after the
first hour of an eight-hour dialysis cycle, the mass transfer and
clearance of proteins of large molecular weight (> 68,000) was contin-
uous throughout the eight hours. The clearance of proteins of small
molecular weight (< 15,000) showed similar kinetics to small solutes (<
200). These results indicate that long dwell times (6 or 8 hr) of peritoneal
dialysis are detrimental for the loss of large molecular weight proteins
(such as albumin and immunoglobulins) in view of the negligible
dialysance of both small solutes (creatinine and potassium) and "inter-
mediate molecules" (represented by the small molecular weight pro-
teins) during the latter hours of long dwell cycles. Thus we suggest that
substituting CAPD (3 x 8 hr or 4 x 6 hr) with CCPD (6 x 1 hr) may limit
protein loss in these patients.
Since its introduction in 1976 [1], continuous ambulatory
peritoneal dialysis (CAPD) has been widely accepted as a
treatment for end-stage renal disease [21 resulting in a survival
similar to that obtained in patients maintained on hemodialysis
[3]. One of the major disadvantages of CAPD is protein loss in
the nephrotic range: 5 to 15 glday [4]. Such a loss of plasma
proteins into the dialysis fluid may lead to depletion of the
visceral protein pool unless replenished by an adequate dietary
intake [5].
In the present study we investigated the kinetics of protein
loss as a function of molecular weight, dwell-time and duration
of dialysis, and compared it to the kinetics of small solutes
clearance. These results may be used for planning of alternative
regimens for peritoneal dialysis that will preserve the dialysis
efficiency while minimizing the loss of high molecular weight
proteins.
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Dialysis procedure
All patients had a Tenckhoff peritoneal catheter and were on
CAPD for one day to 58 months. They were dialyzed continu-
ously with three to four exchanges daily using 2 liter plastic
bags of Travenol® Dianeal, 1.5% Dextrose (Travenol Labora-
tories, Ashdod, Israel). Dehydrating solutions (4.25% Dex-
trose), were used intermittently when indicated. The daily
energy intake was about 30 Kcallkg in addition to calories
derived from dextrose in the dialysis fluid. The mean daily
protein intake was 1.5 g/kg of body weight, and their diet was
supplemented with vitamins, calcium and aluminium hydrox-
ide.
Study protocol
Two liter bags of Travenol® Dianeal 1.5% dextrose solutions
were used for the exchanges. Calculations were based on our
own determinations of volume 2.1 0.005 liter and dextrose
concentration 67.3 0.9 mmol/liter (mean SD, N = 12). The
effluents were collected in each study following sequential
cycles of varying dwell time: eight hours (usually from midnight
to 8 a.m.), four hours and one hour, respectively, without
disruption of CAPD. No study was performed if the eight hour
effluent contained more than 100 cells per d. All patients were
recumbent and fasting during collection of samples (17 hr).
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Methods
Patients
Thirteen patients, (5 females and 8 males, aged 18 to 73 years)
with end-stage renal failure and undergoing continuous ambu-
latory peritoneal dialysis were studied. The etiology of their
kidney disease and other clinical characteristics are detailed in
Table 1. None of the patients was obese, suffered from diabetes
mellitus, nephrotic syndrome or overt liver disease. None of the
patients has been previously treated by hemodialysis or had a
kidney transplant. Five patients (prospective group, patients 1
to 5) had been recruited before the start of CAPD treatment and
were studied during their training period, at one, three and six
months on CAPD. The other eight patients (6 to 13, Table 1)
were studied at 6 to 58 months on CAPD. None of the studies
was conducted within one month of a peritonitis episode. The
study was approved by the Human Studies Committee of the
Hospital, and an informed consent was obtained from each
subject.
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Table 1. Clinical characteristics and initiala blood analysis in CAPD patients
Etiology of Duration Blood Glucose Urea Creatinine
No.
Age
yr Sex
kidney
disease
Drug
therapy
of CAPD
months
pressure
mm Hg
Weight
kg
Height
m
Hct
%
Albumin
mmol/liter gluier
1 40 F UNK — 0-6 190/100 51 1.52 26.8 4.9 23.3 0.70 44.0
2 58 F CGN Aten 0-6 190/120 71 1.66 28.5 5.6 27.7 1.21 42.0
3 42 F UNK — 0-6 170/100 45 1.64 27.5 4.8 17.5 0.57 38.0
4 18 M CGN — 0-3 170/100 52 1.76 25.1 4.2 25.5 0.70 37.0
5 73 M HT Nif, Clon 0-3 180/80 66 1.68 32.4 5.8 25.5 0.92 44.0
6 59 M HT MD, Ver 6 165/80 84 1.72 29.8 4.9 28.3 1.09 40.0
7 35 M CPN — 14, 32 110/70 71 1.78 30.1 5.3 27.7 1.13 41.0
8 56 M UNK — 18 140/90 56 1.38 35.8 5.2 25.3 0.88 40.0
9 66 F UNK — 9 130/85 45 1.45 30.4 6.1 15.3 0.74 39.0
10 50 M UNK — 16 145/80 50 1.59 31.2 5.1 13.5 1.14 46.0
11 53 M UNK — 58 165/85 62 1.70 38.1 4.9 26.2 1.32 43.0
12 38 F UNK — 28 100/70 54 1.54 28.9 5.3 18.0 1.01 38.0
13 39 M CGN — 32 160/110 69 1.77 30.5 4.8 28.2 1.16 42.0
a Before the start of CAPD treatment
Abbreviations are: Hct, hematocrit; UNK, unknown; CGN, chronic glomerulonephritis; HT, hypertension; CPN, chronic pyelonephritis; Aten,
atenolol; Nif, nifedipine; Clon, clonidine; MD, alpha methyldopa; Ver, verapamil.
Sample collection and analysis
During each study two venous blood samples were obtained
at 8 a.m. and 12 noon. The dialysate effluents were collected
into cooled bags on ice and processed at 4°C. Their volume was
determined and centrifuged together with the blood samples at
2500 x g for 20 minutes. One to two liter aliquots were
concentrated to 10 to 30 ml (30- to 100-fold) by means of
membrane ultrafiltration using an YM-lO membrane and a 300
ml cell (Amicon Corp., Danvers, Massachusetts, USA), using
N2 at 4 kg/cm2 at 4°C. The concentrated dialysate and the
ultrafiltrate were collected separately.
The protein concentration on original, concentrates and
ultrafiltrates of effluent samples was quantified by the method of
Lowry et al using bovine serum albumin as standard [6]. Total
protein and albumin levels in serum, and albumin level in
concentrated effluents were analyzed by standard autoanalyzer
techniques (Technicon Corp. Tarrytown, New York, USA). As
the molecular cutoff of the YM-lO membrane is 10,000 daltons
the proteins determined in the concentrate consisted of high
molecular weight proteins (HMWP), and the ultrafiltrate con-
tained the low molecular weight proteins (LMWP). This sepa-
ration was verified by electrophoresis on sodium dodecyl
sulfate polyacrylamide gel. Samples of serum and unconcen-
trated effluent were analyzed for urea, creatinine, uric acid,
phosphorus, potassium, glucose, by standard autoanalyzer
techniques (Technicon Corp.). Concentrations of IgG, IgA,
1gM and complement components C3 and C4 in serum and
concentrated dialysate were measured by nephelometric meth-
ods [7]. Lysozyme activity was determined on serum and
dialysate samples by a turbidometric method [8]. The sensitiv-
ities of the protein determination methods were as follows:
protein by the method of Lowry et al [6] — 4 mg/liter; albumin
by the autoanalyzer technique was 1 g/liter; IgG, IgA and
1gM — 10 mg/liter; C3 — 14 mg/liter; C4 — 2.2 mg/liter and for
lysozyme 0.5 mg/liter.
Calculations and data analysis
The optimal design for studying the kinetics of protein loss
during CAPD calls for sampling of small aliquots from the
peritoneal effluent at regular intervals from initiation of an eight
hour dialysis cycle. Such a study was not feasible in our
patients because of ethical and methodological reasons. We
were concerned that such samplings might have added to the
propensity of peritonitis in these patients. The sensitivity of our
methods used for the determinations of various protein concen-
trations in the effluent necessitated sampling of large volumes of
dialysate, which would have perturbed the kinetics of protein
loss. Therefore, we preferred to study three consecutive cycles
of varying length (8,4, and 1 hr) in each individual, and calculate
the kinetics at different time intervals by subtractions as ex-
plained below. We were concerned about the possible diurnal
effects and the order of studies. In preliminary studies (not
shown) we have validated our study protocol both by showing
no diurnal effect on the kinetics of protein loss (3 x 8 hr daily
cycles in five patients, each studied twice) and by showing no
appreciable effect to randomization of the order of cycles
studied (8,4,1 when compared to both 8,1,4 and 1,4,8). Further-
more, the results detailed in the present article show no effect of
the duration of CAPD treatment in five patients studied pro-
spectively for six months (N = 18), corroborating the validity
and reproducibility of the study protocol.
Peritoneal mass transfer (mass/hr) and clearance of solutes
(mI/mm) were calculated as follows: Ye . Ce/T and Ve . Ce!
t. P, respectively, where: Ye = total dialysate effluent volume
(ml); Ce = dialysate effluent concentration of solutes; T and t =
dwell time in hours and minutes, respectively, and P = serum
concentration (average of the two determinations). For glucose
mass transfer and clearance the following formulas were used:
(Vi . Ci — Ye . Ce)/T and (Yi . Ci — Ye . Ce)/t . Ci, respec-
tively, where Vi = total dialysate influent volume (ml) and Ci =
influent dialysate glucose concentration. These calculations
were used for estimation of both mass transfer and clearance
during the studied dwell times of one, four and eight hours. For
one to four hour and four to eight hour periods of an eight-hour
dwell time the mass transfer and clearance of solutes were
calculated for each study separately using the following formu-
las: (Ce2 Ve2 — Ce1 . Ye1)/(T2 — T1) and (Ce2 . Ve2 —
Ce1 . Ve1)!(t2 — t1) . P, respectively, where the subscript 2
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Table 2. Peritoneal loss of solutes during an 8 hour cycle of CAPD
Mass transfer Clearance
mg/hr/I .73 m2 mi/mini! .73 m2
Potassium 1.11 004b 3.95 0.13
Urea 396.2 24.6 4.95 0.18
Creatinine 23.7 1.35 3.87 0.10
Uric acid 15.4 0.47 3.53 0.10
Inorganic phosphorus 11.3 0.62 3.71 0.13
Glucose (absorbed) 2177.0 94.4 2.99 0.13
Total protein 609.1 38.6 0.166 0.013
LMWPC 80.9 5.14 —
Lysozyme 0.9 0.08 0.685 0.06
HMWPC 462.2 37.45
Albumin 255.7 15.19 0.121 0.009
IgG 51.7 4.41 0.090 0.009
IgA 9.8 0.89 0.073 0.007
C3 5.4 0.58 0.089 0.010
C4 1.3 0.10 0.075 0.006
1gM 2.7 0.43 0.052 0.007
a The results represent 27 studies performed in 13 patients and are
expressed as mean 5EM. All patients were recumbent and fasting.
Two liters of Dianeal 1.5% were used for 8 hr exchanges.
b The results are expressed as mEq/hr/l .73 m2
LMWP—low molecular weight proteins (< 10.000), HMWP—high
molecular weight proteins (> 10.000). These fractions were obtained by
ultrafiltration through a YM-lO (Amicon) membrane.
represents the longer cycle (4 and 8 hr) and the subscript 1
represents the shorter cycles (1 and 4 hr, respectively).
All data were normalized for a body surface area of 1.73 m2
and evaluated by Student's t-test, analysis of variance and
linear regression [9].
Results
Effect of the molecular mass and cycle length on peritoneal
clearance
The peritoneal loss, calculated both as mass transfer and
clearance, of solutes having a wide range of molecular sizes
during eight hours of an uninterrupted CAPD cycle is detailed in
Table 2. From this table and Figure 1A it is evident that the
peritoneal clearance of these solutes is inversely correlated to
their respective molecular mass. For the small molecular weight
solutes (< 200) this was r =
—0.696, P < 0.05 and for the large
molecular weight solutes (> 68,000) r =
—0.912, P <0.0005.
When these losses during a regular cycle of eight hours were
divided into time intervals: (0 to 1, 1 to 4 and 4 to 8 hr) a major
difference was observed between the behavior of small and
large molecular weight solutes (Table 3). The mass transfer of
small molecular weight solutes revealed a remarkable drop with
the progress of the cycle duration, whereas the mass transfer of
large molecular weight solutes did not change much (Table 3,
Fig. 2). A similar difference between small and large molecular
weight solutes was also observed when the peritoneal clearance
was calculated (Table 3). The peritoneal mass transfer and
clearance of the large solutes (molecular weight > 68,000)
showed a biphasic pattern during the eight hour exchange.
Their loss decreased significantly during the mid-interval (1 to 4
hours) when compared to 0 to 1 and 4 to 8 hour periods (P <
0.05; Table 3, Fig. 2).
As a result of the differential behavior between small and
large molecular weight solutes, the linear regression between
their peritoneal clearances and their respective molecular
weights varied among the different dwell time periods (Fig. lB).
Unlike the large molecular weight solutes which showed similar
slopes during the various time intervals (—10.7, —14.1 and
—14.6 for 0 to 1, 1 to 4 and 4 to 8 hr periods, respectively), the
clearance of small molecular weight solutes revealed a remark-
able change in these slopes during the different time periods
(—0.05, —0.33, and +0.58, for 0 to 1, 1 to 4 and 4 to 8 hr,
respectively; Fig. 1B). One may calculate from Table 3 that for
a peritoneal loss of 1 g of urea at intervals 0 to 1, 1 to 4 and 4 to
8 hours of the cycle, 0.18, 0.55 and 2.51 g of albumin are lost,
respectively.
It is of special interest that proteins of small molecular
weight, such as lysozyme (molecular wt 14580), and the pro-
teins that underwent ultrafiltration during concentration of the
peritoneal effluent (molecular wt < 10,000) showed a kinetic
pattern similar to that of small molecular weight solutes (< 200)
rather than that observed in plasma proteins of higher molecular
mass (Table 3, Fig. 2). The clearance of these "middle"
molecular weight proteins decreased with the prolongation of
dwell time. Therefore, we may conclude that during long cycles
the loss of high molecular weight proteins is not accompanied
by efficient dialysis.
Effect of duration of CAPD treatment on peritoneal clearance
and serum levels of solutes
No statistically significant changes were observed in the
peritoneal clearance (8 hr dwell) of all studied solutes, of either
small, intermediate or large molecular weight, during 58 months
of dialysis (Table 4; F value for analysis of variance <1.0, P>
0.5). Similar results were observed also for the initial rate
during the first hour of dwell (not shown). Nonetheless, we
have observed a tendency for changes in the serum level of
some of the studied solutes during the 58 months (Table 5).
Mean serum creatinine concentration increased from 0.8 to 1.2
mmollliter during three years of CAPD, without a parallel drop
in its peritoneal clearance during this period (Tables 4, 5).
Lysozyme showed a tendency to lower serum levels at one to
six months of dialysis without a concomitant increase of its
peritoneal clearance during this period. Serum albumin showed
a tendency for a drop of about 5 g/liter during three years of
dialysis without a remarkable change in its clearance.
Most solutes studied revealed a positive significant linear
correlation between their peritoneal loss and their respective
blood levels (Table 6, Fig. 3). The mass transfer of albumin was
negatively correlated to its plasma levels, unlike all other
studied solutes of both small and large molecular weight, which
showed a positive correlation (Table 6).
Discussion
In the present study we investigated the possible contribution
of some factors to the kinetic characteristics of protein loss into
peritoneal fluid during CAPD. We have followed prospectively
five patients for six months and examined another eight patients
up to 58 months on CAPD. Few studies have been performed to
date on the peritoneal transport kinetics in CAPD patients
followed for more than one year [10—14]. These studies have
shown that in most patients no significant changes occur with
duration of dialysis in the peritoneal mass transfer of low,
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Fig. 1. Effect of molecular mass on the peritoneal clearance of solutes during 0—8 hours () (A) and 0—1 hr (• •), 1—4 hr (A----A) and 4—8 hr
(0—.—0) (B) of an 8 hour CAPD cycle. The clearance of each solute was calculated from the average serum levels of two determinations during
the study, and the mass recovered sequentially in the peritoneal effluent at following dwell times: 8 hr, 4 hr and 1 hr (27 studies in 13 patients).
The mass lost during 1—4 hr and 4—8 hr periods were calculated by subtracting the 1 hr from 4 hr, and 4 hr from 8 hr values, respectively. The
regression equations obtained were as follows: A. Small solutes (molecular < 200): Log y = 3.065 — 0.28lx, r = —0.696, P < 0.05; large solutes
(molecular wt> 68000): Log y = 6.507 — l4.44x, r = 0.912, P < 0.0005. B. Small solutes 0—i hr: Log y = 2.754 — 0.05x, r = —0.884, P < 0.025;
1—4 hr: Logy = 3.3 —0.331x, r =
—0.743, P <0.05; 4—8 hr: Logy = 1.112 + 0.579x, r = +0.898, P < 0.01; large solutes 0—1 hr, Logy = 6.311
— l0,7l6x, r = —0.968, P < 0.005; 1—4 hr: Log y = 6.213 — 14.085x, r = —0.885, P < 0.005; 4—8 hr: Log y = 6.631 — 14.582x, r = —0.857, P <
0.01.
Table 3. Effect of dwell time on peritoneal loss of solutes during CAPD
Dwell time, hours
Mass transfer mg/hrfl.73 m2 Clearance mI/mm/i.?3 m2
0—1 1—4 4—8 0—1 1—4 4—8
Potassium 5.1 0.2" 1.2 0.1" 0.2 004b.d. 18.47 0.95 4.18 0.22" 0.78 0l5
Urea 1676.7 91.5 381.1 23.1 108.7 l7.3e 21.71 0.98 5.01 0.28" 1.36 0.20"
Creatinine 84.3 4.7 21.9 1.3" 11.2 l.1" 14.72 1.04 3.69 0.20" 1.82 015d,e
Uric acid 49.8 3.9 16.1 1.0" 8.3 11.59 0.94 3.67 0.22" 1.87 O.l3"
Inorganic phosphorus
Glucose (absorbed)
35.5 2.5
6822.9 890.9
10.1 0.9" 7.2 0.6"
2443.3 274.9" 1205.8 l20.8Ie
11.85 0.81
9.38 1.22
3.30 0.23"
3.35 0.37"
2.34 0.16"1.65 0I6'
Total protein
LMWP'
1297.8 109.4
522.3 48.0
454.2 505d 567.0 53.7"
36.5 50d 29.9 5.1"
0.35 0.04 0.13 0.02" 0.16 0.02"
Lysozyme 7.0 2.0 1.0 0.3" 0.4 0.IIC 5.14 1.53 0.57 0.18" 0.31 0.091
HMWP" 587.1 62.5 382.0 39.4" 487.9 54.4 — — —
Albumin 303.5 33.0 211.6 16.7" 273.3 21.2e 0.14 0.02 0.1 001d 0.13 0.01
IgG
IgA
68.1 9.3
13.4 2.2
38.5 3.4" 53.4 5.8e
7.4 0.8" 10.6 l.2e
0.12 0.01
0.09 0.01
0.07 0.01"
0.06 0.01"
0.09 o.ole
0.08 0.01
C3
C4
5.3 0.6
1.9 0.5
4.1 0.5 5.9 0.9
0.9 01d 1.4 0.2
0.09 0.01
0.09 0.01
0.070 0.01
0.05 0.01"
0.10 0.01
0.08 0.0i
1gM 2.3 0.4 1.9 0.3 3.6 0.8 0.04 0.01 0.03 0.01 0.06 o.ole
a The results represent 26 studies performed in 13 patients and are expressed as mean SEM. Two liters of Dianeal' 1.5% were used for three
consecutive exchanges of 8, 4 and 1 hours. The solute loss during the dwell times of 1—4 and 4—8 hours were calculated from the 0—i, 0—4 and 0—8
hr losses.b The mass transfer of potassium is expressed in mEq/hr/1 .73 m2
LMWP-low molecular weight and HMWP-high molecular weight proteins, see Table 2
d P < 0.05 when compared to 0—1 hr time interval
P < 0.05 when compared to 1—4 hr time interval
A
0.05 0.1 2.5 3.5 4.5 0 0.05 0.1 0.15 1 5 10 15 20 25
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Table 4. Effect of duration of CAPD treatment on peritoneal clearance of solutes during an 8 hour cyclea
Months on dialysis
0
(5)b
1
(5)
3 6
(5) (4)
9—18
(4)
28—58
(4)
ml/min/1.73 m2
Potassium 3.97 0.32 3.83 0.24 3.96 0.40 3.94 0.44 4.16 0.13 3.89 0.29
Urea 5.30 0.30 5.18 0.42 5.21 0.58 4.65 0.55 4.79 0.15 4.33 0.33
Creatinine 3.66 0.24 3.92 0.08 4.00 0.35 3.70 0.26 4.08 0.21 3.84 0.23
Uric acid 3.21 0.31 3.54 0.06 3.59 0.28 3.42 0.20 3.80 0.23 3.67 0.24
Inorganic phosphorus 3.24 0.33 3.77 0.15 3.88 0.37 3.63 0.16 4.18 0.33 3.66 0.41
Glucose (absorbed) 2.68 0.44 3.01 0.19 2.99 0.11 2.68 0.08 3.37 0.48 3.31 0.15
Totalprotein 0.14 0.17 ±0.02 0.18 0.20±0.05 0.16±0.01
Lysozyme 0.67 0.06 0.70 0.13 0.84 0.22 0.70 0.16 0.68 0.03 0.48 0.06
Albumin 0.10 0.02 0.13 0.02 0.13 0.02 0.14 0.02 0.12 0.02 0.12 0.01
IgG 0.07 0.01 0.09 0.01 0.09 0.01 0.09 0.02 0.09 0.03 0.12 0.03
IgA 0.06 0.01 0.08 0.02 0.08 0.01 0.08 0.01 0.08 0.02 0.07 0.01
C3 0.08 0.02 0.09 0.02 0.09 0.01 0.10 0.02 0.10 0.04 0.09 0.01
C4 0.07 0.01 0.08 0.01 0.08 0.01 0.07 0.01 0.07 0.02 0.07 0.01
1gM 0.03 0.01 0.04 0.01 0.05 0.01 0.05 0.01 0.06 0.02 0.08 0.03
a The results represent 27 studies performed in 13 patients according to the duration of CAPD and are expressed as mean SEM. 0, 1 and 3
months represent repeated studies in the prospective group-patients No. 1—5 (Table 1) and the 6 months determination are studies performed in
patients No. 1—3 and 6. The remainder were studied once at the time stated in Table I, in addition to patient No. 7 who was restudied at 32 months.
None of the differences were statistically significant by analysis of variance (F < 1.0).b Figures in parentheses represent number of patients studied at each time period
middle and large molecular weight solutes. Our study confirms months of CAPD. Moreover, no consistent differences in the
these findings, that is, no major changes were observed in the peritoneal transport kinetics were observed with age, sex or
clearance of all investigated solutes from smallest molecules, number of peritonitis episodes [14—18].
such as potassium, up to the largest, such as 1gM, during 58 The most important single factor found to affect the perito-
500 10
300
Lysozyme
5
LMWP
+
. *I
.
0 — — ri ,—.—i
HMWP
:n500250 500250
Albumin
nn
0-1 1-4 4-8 0-1 1-4 4-8
Dwell time, hours
gA Fig. 2. Effect of dwell time on the peritoneal
mass transfer of small (molecular wt < 200,
upper panels), intermediate size (middle
20 panels) and large molecular weight solutes(molecular wt > 68,000, lower panels), in 13
patients on CAPD. The bars represent mean
SEM of 27 studies. The individual data were
10 calculated for the various time intervals as
detailed in the legend to Figure 1. * represents
statistical significance (P < 0.05) by paired0 Student's t-test compared with both 0—1 hr
0-1 1-4 4-8 and 4—8 hr intervals; ** < 0.05 by paired
test compared with 0—I h interval.
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Table 5. Effect of duration of CAPD treatment on plasma levels of solutesa
Months on dialysis
0
(5)b
1
(5)
3
(5)
6
(4)
9—18
(4)
28—58
(4) FC
Potassium mmol/liter 5.1 0.3 4.8 0.3 4.8 0.3 4.5 0.2 4.4 0.6 4.7 0.4 0.38
Urea mmol/liter 23.9 1.54 19.8 1.7 22.0 3.5 21.2 2.5 20.5 3.1 26.5 2.8 0.69
Creatjnjnemmol/ljter 0.8±0.1 0.8±0.1 0.9±0.1 0.9±0.1 1.0±0.1 1.2±0.1 2.32
Uric acid mmol/liter 0.5 0.03 0.4 0.03 0.4 0.02 0.5 0.02 0.4 0.02 0.4 0.02 0.62
Inorganic phosporous mmol/liter 1.7 0.2 1.4 0.03 1.6 0.2 1.6 0.1 1.5 0.2 2.2 0.2 1.83
Glucose mmol/liter 5.1 0.3 5.5 0.2 5.0 0.1 5.1 0.1 5.4 0.2 5.1 0.1 1.06
Total protein g/liter 67.0 3.0 62.9 2.0 60.5 3.5 60.1 3.9 64.7 4.0 62.7 1.0 0.55
Lysozyme mg/liter 23.4 1.2 16.4 1.5 17.6 2.2 25.5 1.8 26.0 1.9 28.4 3.8 4.05C
Albumin g/liter 40.3 1.6 37.0 1.7 36.0 2.0 35.5 0.4 36.3 2.9 35.5 2.4 0.46
IgG g/Iiter 10.1 1.5 9.9 1.2 9.6 1.3 9.6 0.6 11.5 1.6 9.3 0.9 0.26
IgA glliter 2.1 0.2 2.3 0.3 2.2 0.2 2.2 0.2 3.0 0.6 2.2 0.3 0.69
C3 glliter 1.0 0.1 1.0 0.1 0.9 0.1 0.9 0.2 1.2 0.1 1.2 0.3 1.92
C4 g/liter 0.3 0.03 0.3 0.02 0.2 0.02 0.3 0.1 0.4 0.1 0.3 0.04 2.16
IgMg/liter 0.9 0.2 1.0 0.2 1.0 0.2 0.8 0.2 1.1 0.1 0.9 0.2 0.17
a The studies were performed on patients detailed in Table 5 and are expressed as mean SEM.
b Figures in parentheses represent number of patients studied at each time period.
C Analysis of variance, P < 0.05 when the value for F is greater than 2.8.
Table 6. Pearson's correlation coefficients between plasma level and
8 hour peritoneal mass transfer of solutes in patients undergoing
CAPD
r P
Potassium 0.370 <0.05
Urea 0.818 <0.0005
Creatinine 0.872 <0.0005
Uric acid 0.419 <0.05
Inorganic phosphorus 0.626 <0.0025
Glucose —0.275 NS
Lysozyme 0.388 <0.05
Albumin —0.609 <0.005
IgG 0.371 <0.05
IgA 0.416 <0.05
C3 0.113 NS
C4 0.123 NS
1gM 0.334 <0.05
The correlation was computed from 18 studies performed in 5
patients studied prospectively for 6 months (patients 1—5, Table I). NS,
not significant, F> 0.05
neal clearance kinetics of solutes and proteins was the molec-
ular mass, suggesting membrane restriction based on size
exclusion, in accordance with results observed by previous
investigators [19—261. Although the negative exponential rela-
tionship between clearance and molecular mass was maintained
during an eight hour dwell, the mass transfer and clearance of
individual molecules were affected in a different manner during
the cycle duration. The mass transfer of small molecular weight
solutes (<200) decreased remarkably with increasing dwell time
(0 to 1> 1 to 4 > 4 to 8 hr), confirming previous reports [27—291.
Unlike small molecules, large molecular weight solutes (>
68,000) showed a continuous loss. This discrepancy between
small and large solutes has also been observed by other
investigators, and it was concluded that the net removal of
proteins was independent of the dwell time [28].
The peritoneal mass transfer and clearance of high molecular
weight proteins (large solutes) showed biphasic changes during
an eight hour cycle in our CAPD patients, demonstrating a
small but significant temporary decrease of these parameters
after the first hour of dialysis (1 to 4 hr) with a subsequent
increase to the initial rate. Blumenkrantz et al [14] and Miller et
al [30] showed that the protein loss during maintenance inter-
mittent peritoneal dialysis was greatest during the initial hours
of dialysis, and progressively decreased with subsequent ex-
changes. These authors suggested that this phenomenon is
caused by a washout of the residual protein present in the
peritoneal cavity. Our results, which were obtained from con-
secutive uninterrupted cycles of CAPD, cannot be explained by
this suggestion. Alternatively, the biphasic pattern observed in
the clearance of proteins of high molecular weight across the
peritoneal membrane throughout an eight hour cycle, may be
attributed to an early irritant effect of the hypertonic dialysate
solution [31, 32], with a subsequent brief and transient perito-
neal interstitial dehydration [33] resulting in a delayed passage
of large molecules to the peritoneal fluid [34, 35]. The late
increase in the clearance of high molecular weight proteins (4 to
8 hr) may be explained by the progressive drop in the dialysate
tonicity caused by glucose absorption. The possible effect of the
peritoneal lymphatic absorption as suggested recently [36] has
not been addressed in the present study. The effect of the
circadian rhythm on the kinetics of protein loss has been
excluded in our study by changing the order of cycles and
conducting some experiments during daytime without affecting
the results. These latter findings are supported by the findings of
Young, Brownjohn and Parsons [25]. The fact that peritoneal
protein losses may be dependent on dwell time has been also
demonstrated by other authors [37—40].
It is interesting that the peritoneal mass transfer and clear-
ance of low molecular weight proteins (< 15,000) were similar
to those observed with small solutes, showing a remarkable
drop after the first hour of dialysis, unlike the peritoneal mass
transfer and clearance of high molecular weight proteins which
were continuous during an 8h dialysis cycle. Therefore, when
studying factors affecting the kinetics of peritoneal excretion of
proteins they should not be pooled, but divided into low and
high molecular weight proteins. Our results indicate that the
daily peritoneal loss of low molecular weight proteins as with
small molecular weight solutes (<200) was mainly during the
first hour of three eight-hour cycles (>50% of the daily loss) and
less than 17 percent of the daily loss during the four to
Peritoneal mass transfer, mg/hr/l.73 m2
eight-hour intervals of the eight-hour dwell time. On the other
hand the daily peritoneal loss of high molecular weight proteins
(>68,000) occurred mainly during the last four hours of dwell
(more than 50% of daily loss at 4 to 8 hr intervals). As low
molecular weight proteins may represent the excretion of
intermediate molecular weight solutes (uremic toxins [22]) and
their kinetic characteristics are similar to those of small solutes,
we suggest that increasing the number of short dialysis cycles is
more effective in the removal of both small solutes and "uremic
toxins" ("middle molecules") than three to four daily ex-
changes of long (6 to 8 hr) cycles. In our opinion, the prolonged
dialysis cycles may be detrimental, particularly after four hours
of dwell, when the increased peritoneal loss of high molecular
weight proteins is not accompanied by significant dialysance of
small and "middle" molecules.
= 6.37X + 169 29 Fig. 3. Correlation between the serum levels
r = 0.386 and 8 hour peritoneal mass transfer of small
p < 0.05 (upper panel) intermediate size (middle panel)
_________________
and large (lower panel) molecular weight
i'o o solutes in 13 CAPD patients (N = 26 studies).All correlations were statistically significant at
P < 0.05 as indicated in the figure.
Blumenkrantz et al in IPD patients [14] and Young et al in
CAPD patients [25] demonstrated that the rate of peritoneal loss
of all investigated proteins were positively correlated to their
respective serum concentrations. We observed a similar corre-
lation for the clearance of lysozyme and immunoglobulins, but
no such correlation could be demonstrated in the clearance of
complement components. This lack of correlation may reflect a
too small interpatient variation in the serum levels of C3 and C4
as noted also by other investigators [14, 41]. In contrast to most
plasma proteins, we observed a negative correlation between
the clearance of serum albumin to its serum concentration, in
agreement with the study reported by Kaysen and Schoenfeld
[34]. This negative correlation may indicate to an inadequate
compensation in the synthetic rate of albumin to replace the
peritoneal loss.
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Recent data suggest that patients undergoing CAPD may be
prone to protein depletion [4, 41] and demonstrate abnormal
(lower) "nutritional parameters" such as total body nitrogen
[42, 43]. A significant decrease in total serum protein, albumin,
IgG, IgA, C3 and other proteins has been reported during CAPD
treatment [4, 14, 41,44,45]. In other studies the serum levels of
proteins in patients on CAPD were maintained at the lower
normal limits [46, 47]. Our results support these latter findings,
demonstrating the lack of statistically significant changes in
serum levels of proteins during long-term CAPD treatment. The
only exception was serum lysozyme, which serum activity
decreased significantly with the start of CAPD treatment,
increased to the initial levels at six months and remained stable
for three years on CAPD. These changes occurred without a
parallel change in its peritoneal clearance. The initial drop in
serum lysozyme could be explained by effective dialysis,
whereas the latter increase correlated to an increase in serum
creatinine levels and therefore can be ascribed to deterioration
of residual renal function occurring during long-term dialysis
treatment [48].
From this study we may conclude that during CAPD the
peritoneal protein transport of low and high molecular weight
proteins reveal different kinetic characteristics. Their loss is
dependent on their molecular mass and their serum concentra-
tion, but are not influenced by duration of CAPD. It is conceiv-
able that substitution to 1 hour x 6 cycles/day peritoneal
dialysis regimen, as practiced during CCPD for the standard 8
hour x 3 or 6 hour x 4 cycles of CAPD, may result in reduction
of protein loss without affecting the clearance of small and
middle molecular weight solutes.
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